Guidelines for the management of hyperlipidemia: How can clinicians effectively implement them?

Autor: Dembowski E; Northwestern University Feinberg School of Medicine, Division of Cardiology. Electronic address: ewa.dembowski@northwestern.edu., Freedman I; Northwestern University Feinberg School of Medicine, Division of Cardiology., Grundy SM; Center for Human Nutrition of the University of Texas, Texas Southwestern Medical Center at Dallas., Stone NJ; Northwestern University Feinberg School of Medicine, Department of Preventive Medicine.
Jazyk: angličtina
Zdroj: Progress in cardiovascular diseases [Prog Cardiovasc Dis] 2022 Nov-Dec; Vol. 75, pp. 4-11. Date of Electronic Publication: 2022 Nov 14.
DOI: 10.1016/j.pcad.2022.11.009
Abstrakt: Guidelines support lowering cholesterol to decrease atherosclerotic cardiovascular disease (ASCVD) risk across the entire lifespan with intensive lifestyle intervention, as well as statin and non-statin pharmacotherapy for those at highest risk. Modest improvements in the initiation, use, and adherence to statin therapy in patients with ASCVD have occurred over the past decades. However, studies continue to document a less than desired implementation of guidelines highlighting a substantial and persistent treatment gap. The success of implementation depends on the consideration of a variety of barriers that exist throughout the healthcare delivery system. Further research is needed to comprehensively evaluate these barriers in order to develop appropriate and sustainable interventions to improve guideline implementation.
Competing Interests: Declaration of Competing Interest Ewa Dembowski, MD, Isaac Freedman, BS, Scott M. Grundy MD, PhD, declare no conflicts of interest. Neil Stone, MD receives an honorarium from Knowledge to Practice, an educational company without pharmaceutical connection.
(Copyright © 2022 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: